461 related articles for article (PubMed ID: 16612775)
21. [Prognostically unfavorable factors in esophagus cancer. III. Operative therapy of esophagus cancer--effect of preoperative measures on prognosis in curative resection].
Weitensfelder W; Redtenbacher M; Haiderer O; Weitensfelder E
Chirurg; 1985 Mar; 56(3):161-5. PubMed ID: 3921318
[TBL] [Abstract][Full Text] [Related]
22. [Value of radiotherapy and chemotherapy in treatment of operable cancers of the esophagus].
Msika S; Hay JM
J Chir (Paris); 2002 Feb; 139(1):17-24. PubMed ID: 12071024
[TBL] [Abstract][Full Text] [Related]
23. [Esophageal carcinoma: guidelines in surgical therapy].
Kremer B; Marxsen J; Grimm H; Stoffregen C; Schmid A; Henne-Bruns D
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():284-9. PubMed ID: 9931626
[TBL] [Abstract][Full Text] [Related]
24. Toxicity of chemotherapy for esophageal carcinoma.
Ilson D
Chest Surg Clin N Am; 1997 Aug; 7(3):551-63; discussion 564. PubMed ID: 9246402
[TBL] [Abstract][Full Text] [Related]
25. Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy.
Fréchette E; Buck DA; Kaplan BJ; Chung TD; Shaw JE; Kachnic LA; Neifeld JP
J Surg Oncol; 2004 Aug; 87(2):68-74. PubMed ID: 15282698
[TBL] [Abstract][Full Text] [Related]
26. Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patterns.
Koshy M; Greenwald BD; Hausner P; Krasna MJ; Horiba N; Battafarano RJ; Burrows W; Suntharalingam M
Am J Clin Oncol; 2011 Jun; 34(3):259-64. PubMed ID: 20686405
[TBL] [Abstract][Full Text] [Related]
27. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
29. [Preoperative radiochemotherapy of esophageal carcinoma. Light at the end of the tunnel?].
Hölscher AH; Metzger R; Schneider PM
Zentralbl Chir; 2000; 125(4):319-25. PubMed ID: 10829311
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer.
Shimakawa T; Naritaka Y; Asaka S; Isohata N; Murayama M; Konno S; Yoshimatsu K; Shiozawa S; Katsube T; Ogawa K
Anticancer Res; 2008; 28(4C):2321-6. PubMed ID: 18751413
[TBL] [Abstract][Full Text] [Related]
31. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial.
Burmeister BH; Thomas JM; Burmeister EA; Walpole ET; Harvey JA; Thomson DB; Barbour AP; Gotley DC; Smithers BM
Eur J Cancer; 2011 Feb; 47(3):354-60. PubMed ID: 21084184
[TBL] [Abstract][Full Text] [Related]
32. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
33. Surgical resection with and without chemotherapy in oesophageal cancer.
Rath GK; Sharma DN; Shukla NK
Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387980
[No Abstract] [Full Text] [Related]
34. [Radio- and chemotherapy of cancer of the esophagus].
Tiret E
Rev Prat; 1999 Jun; 49(11):1186-91. PubMed ID: 10416350
[TBL] [Abstract][Full Text] [Related]
35. [Neoadjuvant treatment of operable esophageal cancers].
Azria D; Ychou M; Senesse P; Dubois JB
Gastroenterol Clin Biol; 1999 Oct; 23(10):1107-8. PubMed ID: 10592891
[No Abstract] [Full Text] [Related]
36. [Principles of treatment in locally advanced esophageal squamous cancer].
Constantinoiu S; Hanna A; Bîrlă R; Anghel R; Tavlas E; Mocanu A; Hoară P
Chirurgia (Bucur); 2010; 105(1):7-14. PubMed ID: 20405674
[TBL] [Abstract][Full Text] [Related]
37. A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery.
Albregts M; Hulshof MC; Zum Vörde Sive Vörding PJ; van Lanschot JJ; Richel DJ; Crezee H; Fockens P; van Dijk JD; González González D
Int J Hyperthermia; 2004 Sep; 20(6):647-59. PubMed ID: 15370820
[TBL] [Abstract][Full Text] [Related]
38. [Surgical treatment of esophageal tumors including local ablation].
Hölscher AH; Vallböhmer D
Zentralbl Chir; 2007 Apr; 132(2):W18-36; quiz W37-8. PubMed ID: 17516311
[No Abstract] [Full Text] [Related]
39. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.
Mooney MM
J Surg Oncol; 2005 Dec; 92(3):230-8. PubMed ID: 16299790
[TBL] [Abstract][Full Text] [Related]
40. Surgical resection with and without chemotherapy in oesophageal cancer.
Bosset JF; Mercier M; Triboulet JP; Conroy T; Seitz JF
Lancet; 2002 Oct; 360(9340):1173-4; author reply 1175. PubMed ID: 12387978
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
